These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7982919)

  • 1. Osteonectin in matrix remodeling. A plasminogen-osteonectin-collagen complex.
    Kelm RJ; Swords NA; Orfeo T; Mann KG
    J Biol Chem; 1994 Dec; 269(48):30147-53. PubMed ID: 7982919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human osteoblast and megakaryocyte-derived osteonectin (SPARC).
    Kelm RJ; Hair GA; Mann KG; Grant BW
    Blood; 1992 Dec; 80(12):3112-9. PubMed ID: 1467517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of N-linked glycosylation in human osteonectin. Effect of carbohydrate removal by N-glycanase and site-directed mutagenesis on structure and binding of type V collagen.
    Xie RL; Long GL
    J Biol Chem; 1995 Sep; 270(39):23212-7. PubMed ID: 7559469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex formation of human thrombospondin with osteonectin.
    Clezardin P; Malaval L; Ehrensperger AS; Delmas PD; Dechavanne M; McGregor JL
    Eur J Biochem; 1988 Aug; 175(2):275-84. PubMed ID: 3402455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of human plasminogen to basement-membrane (type IV) collagen.
    Stack MS; Moser TL; Pizzo SV
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):103-8. PubMed ID: 1599390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
    Nesheim M; Fredenburgh JC; Larsen GR
    J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ; Fredenburgh JC; Weitz JI
    J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation.
    Kelm RJ; Mann KG
    J Biol Chem; 1991 May; 266(15):9632-9. PubMed ID: 2033056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC).
    Rosenblatt S; Bassuk JA; Alpers CE; Sage EH; Timpl R; Preissner KT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):311-9. PubMed ID: 9164872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of nonproteolytic active site formation in plasminogen.
    Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
    Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation with alpha-2-antiplasmin of Glu-plasminogen activation by tissue activator on fibrin].
    Hrynenko TV; Zadorozhna MB; Iusova OI
    Ukr Biokhim Zh (1999); 2006; 78(3):106-12. PubMed ID: 17100317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
    J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.
    Okada K; Nonaka T; Matsumoto H; Fukao H; Ueshima S; Matsuo O
    Thromb Res; 1994 Oct; 76(2):211-20. PubMed ID: 7863470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone chondroadherin promotes attachment of osteoblastic cells to solid-state substrates and shows affinity to collagen.
    Mizuno M; Fujisawa R; Kuboki Y
    Calcif Tissue Int; 1996 Sep; 59(3):163-7. PubMed ID: 8694892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The partial degradation of osteonectin by a bone-derived metalloprotease enhances binding to type I collagen.
    Tyree B
    J Bone Miner Res; 1989 Dec; 4(6):877-83. PubMed ID: 2610022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin.
    Silverstein RL; Harpel PC; Nachman RL
    J Biol Chem; 1986 Jul; 261(21):9959-65. PubMed ID: 2942536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.